Volumetric Analysis in the Assessment of Therapy Response by CT

Completed

Conditions studied: Multiple Diseases

In brief

To compare the volumetric response achieved using semi-automated computer techniques with the uni-dimensional (RECIST) and bi-dimensional (WHO) criteria as part of clinical trials running at MSKCC, testing new agents for different types of solid tumors.

Key facts

Study ID

NCT00582751

Run by

Memorial Sloan Kettering Cancer Center

People needed

26

Starts

2007-11-01

Expected to finish

2010-11-01

Last updated by the study team

2010-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Registered and being treated on one of the following therapeutic protocols:
• 06-043, 07-052, 07-057, 07-112, 07-116, 08-093, and 08-054
• Have at least one measurable lesion* as per RECIST criteria situated in lung, liver or lymph node meeting RECIST criteria noted on a baseline CT scan.
• Baseline** and at least one follow-up CT scan to likely to be obtained at an MSKCC facility
• All patients must be > or = to 18 years old
• The measurable lesions are metastatic in the liver, lung and lymph nodes. The algorithms do not distinguish between primary and metastatic disease, therefore, in selected cases, a primary lesion such as in the liver or lung may also be assessed.
• Baseline CT are prefer but if not able to obtain for volumetric reconstructions follow up studies will still be use for other objectives if the study.

You may not qualify if…

• Pregnant or lactating women

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.